MedTrace Logo

Efficacy, Safety and Local Tolerability Study of Chloroprocaine 3% Gel Eye Drops in Healthy Volunteers

NCT04779606 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 105

Last updated 2021-09-16

Study results available
· View outcomes & findings →

Summary

The study evaluate the efficacy, safety and local tolerability of Chloroprocaine 3% ophthalmic gel as compared to matching placebo in healthy subjects.

Conditions

  • Healthy Subjects

Interventions

DRUG

Ocular gel

3 drops instilled in the right eye

Sponsors & Collaborators

  • Sintetica SA

    lead INDUSTRY

Principal Investigators

  • Milko Radicioni · CROSS Research S.A., Phase I Clinical Unit, Arzo, Switzerland

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-06-16
Primary Completion
2020-10-13
Completion
2020-10-20

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04779606 on ClinicalTrials.gov